EVERTEC (EVTC) Competitors

HealthEquity (NASDAQ:HQY) and EVERTEC (NYSE:EVTC) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.

Does the media refer more to HQY or EVTC?

In the previous week, HealthEquity had 26 more articles in the media than EVERTEC. MarketBeat recorded 28 mentions for HealthEquity and 2 mentions for EVERTEC. EVERTEC's average media sentiment score of 1.67 beat HealthEquity's score of 0.57 indicating that EVERTEC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	9 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
EVERTEC	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has better valuation and earnings, HQY or EVTC?

EVERTEC has lower revenue, but higher earnings than HealthEquity. EVERTEC is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.24B	7.21	$55.71M	$1.37	75.68
EVERTEC	$868.96M	2.73	$79.72M	$1.99	18.72

Do institutionals & insiders have more ownership in HQY or EVTC?

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 96.8% of EVERTEC shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by company insiders. Comparatively, 0.6% of EVERTEC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the MarketBeat Community believe in HQY or EVTC?

HealthEquity received 260 more outperform votes than EVERTEC when rated by MarketBeat users. Likewise, 70.40% of users gave HealthEquity an outperform vote while only 59.30% of users gave EVERTEC an outperform vote.

Company	Underperform	Outperform
HealthEquity	Outperform Votes 547 70.40%	Underperform Votes 230 29.60%
EVERTEC	Outperform Votes 287 59.30%	Underperform Votes 197 40.70%

Do analysts prefer HQY or EVTC?

HealthEquity presently has a consensus target price of $118.09, indicating a potential upside of 13.90%. EVERTEC has a consensus target price of $40.00, indicating a potential upside of 7.38%. Given HealthEquity's stronger consensus rating and higher possible upside, research analysts plainly believe HealthEquity is more favorable than EVERTEC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00
EVERTEC	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Which has more volatility & risk, HQY or EVTC?

HealthEquity has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, EVERTEC has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500.

Is HQY or EVTC more profitable?

EVERTEC has a net margin of 10.20% compared to HealthEquity's net margin of 8.41%. EVERTEC's return on equity of 33.01% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	8.41%	9.70%	6.08%
EVERTEC	10.20%	33.01%	8.85%

Summary

HealthEquity beats EVERTEC on 12 of the 19 factors compared between the two stocks.